Biome Australia Limited (BIO.AX)
AUD 0.47
(-5.05%)
AUD 0.47
(-5.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -1.91 Million AUD | 41.63% |
| 2023 | -3.27 Million AUD | 27.27% |
| 2022 | -4.5 Million AUD | 18.42% |
| 2021 | -5.52 Million AUD | -112.02% |
| 2020 | -2.6 Million AUD | -37.42% |
| 2019 | -1.89 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -1.58 Million AUD | -72.88% |
| 2024 FY | -1.91 Million AUD | 41.63% |
| 2024 Q4 | -328.49 Thousand AUD | 0.0% |
| 2024 Q1 | -916.68 Thousand AUD | 46.22% |
| 2023 Q2 | -1.57 Million AUD | -77.98% |
| 2023 FY | -3.27 Million AUD | 27.27% |
| 2023 Q4 | -1.7 Million AUD | -114.89% |
| 2023 Q3 | -793.25 Thousand AUD | 49.58% |
| 2023 Q1 | -883.93 Thousand AUD | 51.25% |
| 2022 Q1 | -1.35 Million AUD | 42.87% |
| 2022 FY | -4.5 Million AUD | 18.42% |
| 2022 Q4 | -1.81 Million AUD | -76.55% |
| 2022 Q3 | -1.02 Million AUD | 57.46% |
| 2022 Q2 | -2.41 Million AUD | -78.17% |
| 2021 Q3 | -1.12 Million AUD | 64.23% |
| 2021 Q4 | -2.37 Million AUD | -110.32% |
| 2021 FY | -5.52 Million AUD | -112.02% |
| 2021 Q1 | -1.72 Million AUD | 0.0% |
| 2021 Q2 | -3.15 Million AUD | -82.87% |
| 2020 FY | -2.6 Million AUD | -37.42% |
| 2019 FY | -1.89 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AdAlta Limited | -5.26 Million AUD | 63.638% |
| Acrux Limited | -9.83 Million AUD | 80.545% |
| Amplia Therapeutics Limited | -4.42 Million AUD | 56.763% |
| BTC Health Limited | 1.05 Million AUD | 281.3% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 84.457% |
| CSL Limited | 5.64 Billion AUD | 100.034% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 95.729% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 103.893% |
| Noxopharm Limited | -7.53 Million AUD | 74.609% |
| PharmAust Limited | -6.65 Million AUD | 71.267% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | 73.543% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 73.377% |
| PYC Therapeutics Limited | -38.85 Million AUD | 95.076% |
| Race Oncology Limited | -13.38 Million AUD | 85.701% |
| Starpharma Holdings Limited | -15.15 Million AUD | 87.379% |
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 119.691% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 86.985% |
| Memphasys Limited | -2.7 Million AUD | 29.244% |
| Nyrada Inc. | -4.56 Million AUD | 58.046% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -31.122% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Bio-Gene Technology Limited | -3.06 Million AUD | 37.526% |
| Zelira Therapeutics Limited | -5.93 Million AUD | 67.781% |
| Patrys Limited | -3.53 Million AUD | 45.941% |
| Dimerix Limited | -25.05 Million AUD | 92.365% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 100.847% |
| Orthocell Limited | -11.68 Million AUD | 83.621% |
| Imugene Limited | -140.93 Million AUD | 98.642% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 78.278% |
| Immutep Limited | -44.93 Million AUD | 95.742% |
| Arovella Therapeutics Limited | -7.19 Million AUD | 73.402% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 90.239% |
| Nanollose Limited | -1.24 Million AUD | -53.081% |
| Invex Therapeutics Ltd | -2.13 Million AUD | 10.329% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | 6.969% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | 33.424% |
| Biotron Limited | -5.15 Million AUD | 62.858% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 95.947% |
| Tissue Repair Ltd | -4.87 Million AUD | 60.762% |
| AnteoTech Limited | -11.72 Million AUD | 83.685% |
| Hexima Limited | -1 Million AUD | -89.664% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 97.062% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 91.324% |
| Avecho Biotechnology Limited | -4.58 Million AUD | 58.31% |
| Actinogen Medical Limited | -12.83 Million AUD | 85.098% |
| Immuron Limited | -5.8 Million AUD | 67.019% |
| Argenica Therapeutics Limited | -5.67 Million AUD | 66.264% |